Formebolona (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Formebolona" in Spanish language version.

refsWebsite
Global rank Spanish rank
4th place
4th place
2nd place
2nd place
3rd place
7th place
11th place
79th place

books.google.com

doi.org

dx.doi.org

  • Gelli D, Vignati E (1976). «Metabolic studies with formebolone (2-formyl-17 (alpha)-methyl-androsta-1,4-diene-11 (alpha), 17 (beta)-diol-3-one) in humans». J. Int. Med. Res. 4 (2): 96-105. PMID 799985. S2CID 86157607. doi:10.1177/030006057600400203. 
  • Felippone F, Resnati G, Scolastico C, Tronconi G (1984). «Synthesis of 2-carboxy-11 beta, 17 beta-dihydroxy-17-methyl-1, 4-androstadien-3-one and related compounds». Steroids 43 (3): 271-82. PMID 6523544. S2CID 54289377. doi:10.1016/0039-128x(84)90045-x. 
  • Dahlberg E, Snochowski M, Gustafsson JA (1981). «Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol». Endocrinology 108 (4): 1431-40. PMID 6970661. doi:10.1210/endo-108-4-1431. 
  • Souness GW, Latif SA, Laurenzo JL, Morris DJ (1995). «11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat». Endocrinology 136 (4): 1809-12. PMID 7895695. doi:10.1210/endo.136.4.7895695. 
  • Souness GW, Morris DJ (1996). «11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat». Hypertension 27 (3 Pt 1): 421-5. PMID 8698448. doi:10.1161/01.hyp.27.3.421. 
  • Fürstenberger C, Vuorinen A, Da Cunha T, Kratschmar DV, Saugy M, Schuster D, Odermatt A (2012). «The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation». Toxicol. Sci. 126 (2): 353-61. PMID 22273746. doi:10.1093/toxsci/kfs022. 

nih.gov

ncbi.nlm.nih.gov

  • Gelli D, Vignati E (1976). «Metabolic studies with formebolone (2-formyl-17 (alpha)-methyl-androsta-1,4-diene-11 (alpha), 17 (beta)-diol-3-one) in humans». J. Int. Med. Res. 4 (2): 96-105. PMID 799985. S2CID 86157607. doi:10.1177/030006057600400203. 
  • Cerutti S, Forlani A, Galimberti E (1976). «Anticatabolic action of formebolone in the castrated rat treated with dexamethasone». Arzneimittelforschung 26 (9): 1673-7. PMID 1036699. 
  • Felippone F, Resnati G, Scolastico C, Tronconi G (1984). «Synthesis of 2-carboxy-11 beta, 17 beta-dihydroxy-17-methyl-1, 4-androstadien-3-one and related compounds». Steroids 43 (3): 271-82. PMID 6523544. S2CID 54289377. doi:10.1016/0039-128x(84)90045-x. 
  • Dahlberg E, Snochowski M, Gustafsson JA (1981). «Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol». Endocrinology 108 (4): 1431-40. PMID 6970661. doi:10.1210/endo-108-4-1431. 
  • Souness GW, Latif SA, Laurenzo JL, Morris DJ (1995). «11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat». Endocrinology 136 (4): 1809-12. PMID 7895695. doi:10.1210/endo.136.4.7895695. 
  • Souness GW, Morris DJ (1996). «11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat». Hypertension 27 (3 Pt 1): 421-5. PMID 8698448. doi:10.1161/01.hyp.27.3.421. 
  • Fürstenberger C, Vuorinen A, Da Cunha T, Kratschmar DV, Saugy M, Schuster D, Odermatt A (2012). «The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation». Toxicol. Sci. 126 (2): 353-61. PMID 22273746. doi:10.1093/toxsci/kfs022. 

semanticscholar.org

api.semanticscholar.org